Found 1,258 investors
Kinarot
United States
Mr. Robert Kamerschen is a Co-Owner & serves as Chairman & Partner at Healtheo360. He served as Advisor at Halyard Capital. He also serves as a Board Member at Dex Media and MDC Partners, and previously at HealthPrize Technologies. He is a very successful change and transformation leader in a number of sales and marketing driven industries, a highly experienced outside director of public and private companies and personal investor. Mr. Kamerschen currently serves as Director of the Board of Engauge, a Halyard Portfolio company. He serves as Chairman and Partner at Healtheo360. From 1988 until 1999, Mr. Kamerschen served as Chairman and Chief Executive Officer of ADVO, Inc., the nation's largest direct mail microtargeting services company with $1 billion in annual revenue (NYSE). Mr. Kamerschen has also served as CEO of DIMAC, Inc., RKO/Six Flags Entertainment, Inc., and Max Factor, Inc. He has also been EVP-Group Executive of Norton Simon, Inc. overseeing five major companies as well as President of Marketing Corporation of America and Chanel Inc. Finally, he has served in senior level marketing and sales positions at Revlon, Inc., Dunkin Donuts, Inc. and Scott Paper Company. Mr. Kamerschen is currently on the Board of Directors of R.H. Donnelley (NYSE), IMS Health (NYSE), Vertrue, Inc. (NASDAQ) and MDC Partners, Inc. (NASDAQ and TSE) along with several private companies. He has previously served on a number of public boards including RadioShack (NYSE), Linens n Things (NYSE) and Playboy Enterprises (NYSE) among others.
Individual/Angel
Kin Capital Partners (Lafayette)
United States
Kin Capital Partners acquires manufacturers and distributors of high end building materials, with an emphasis on doors, windows, casings, and related products. The firm additionally acquires other portion of the supply and delivery components of direct sales of building materials, including designers, retailers, installers, logistics, and related firms.
Private Equity Firm
Kiril Tsemekhman
United States
Mr. Richard Gorelick serves as Board Member at Eventus. He is an Angel Investor. Mr. Richard Gorelick served as Head of Market Structure at DRW Holdings. He was previously a Co-founder and Chief Executive Officer of RGM Advisors, and has a legal and business background. He serves as Board Member at Unchained Capital. He also serves as an associate member director of the Futures Industry Association.[6] Gorelick is a member of the CFTC's Technology Advisory Committee. Before taking his position at RGM, Gorelick was a chief strategy officer with Deja.com, Inc. He first began working with the company as a general counsel. Before Deja.com, Gorelick was a corporate attorney for Coudert Brothers in New York. Gorelick founded RGM with Robbie Robinette and Mark Melton in 2001. Robinette was a software designer at Deja.com. Melton was a cycling friend of Robinette's. Together, their initials form the acronym for RGM. Gorelick holds a JD from the Georgetown University Law Center and a BA in International Relations from the University of Pennsylvania.
Individual/Angel
KKCG
Switzerland
KKCG is a private investment group that actively seeks projects with hidden investment potential. The firm relies on three stable pillars KKCG Oil & Gas, KKCG Entertainment & Technologies, and KKCG Investments. The third, KKCG Investments, provides the basis for investments with long-term growth potential. Another sector in the target is real estate, where the company executes architectural projects that provide a stable yield. It was founded in 1999 and is headquartered in Lucerne, Switzerland.
Private Equity Firm
Klaas Joosten
United States
Mr. Vladimir Lasocki serves as Managing Director and Co-Head of the Carlyle Europe Technology at The Carlyle Group. He also serves as Angel Investor at BidMotion. He serves as Board Member at Envea. He is focused on investment opportunities in Central and Eastern Europe. He is based in London. Prior to joining Carlyle in 2000, Mr. Lasocki was an Associate with Deutsche Bank's principal investments group focusing on communications investments. At Deutsche Bank, Mr. Lasocki was involved in the bank's investments in Airspan (AIRN), Cocom (acquired by Cisco System), Orchestream (LSE:OCH), Transmeta (TMTA) and Xacct (acquired by Amdocs) among others. Prior to joining Deutsche Bank, Mr. Lasocki was with the corporate finance group of Paribas in Paris, London and Prague. Mr. Lasocki has a degree in business administration with a major in finance earned at EM Lyon and the Universite Libre de Bruxelles (Solvay Business School) and an M.A. in European economic studies from the College of Europe in Bruges. A French national, Mr. Lasocki also speaks English and Czech. Mr. Lasocki is a member of the Board of Directors Transics International NV (Euronext:TRAN) and Wall Street Institute Education, SaRL, and he has represented Carlyle on the Boards of Egencia SA (acquired by Expedia), Orthogon Systems Ltd. (acquired by Motorola), Financiere CAMECA SAS (acquired by Ametek), Solsoft SA (acquired by Exaprotect), and PacketLight Networks Ltd (now a member of the Rad Group).
Individual/Angel
Klarman Family Foundation
Boston, Massachusetts, United States
The Klarman Family Foundation believes that it has an obligation to maximize opportunities to improve and enrich the lives of others.
Venture Capital
Klaus Holse
United States
Dr. Hsing Kung serves as Managing Partner at Acorn Campus Ventures. He Co-Founded Pine Photonics in 2000 and served as President/ CEO until merge with Opnext. He has then served as Sr. VP of Opnext Inc until 2005. Currently, he is a partner of Acorn Campus Ventures and Chairman of Luxnet Corporation. His previous experience included co-founder/VP manufacturing of SDL Inc. from 1983 to 1997. He also serves on the boards of several optoelectronics companies. Dr. Kung was former chairman of Monte Jade (West coast) in 2004. In recent years, he has devoted to promote Chinese-American participation in main stream community. He was a former board member of Fremont Union High School District Board. In his tenure, he has made significant contribution to promote multi-culture climate in high schools. In addition, he also involved in many other community programs and foundations. Currently, he serves on United Way Silicon Valley Board, and American Leadership Forum Silicon Valley board. Dr. Kung holds BSEE from National Cheng Kung University, PhD EE from University of California at Berkeley, and MBA from Santa Clara University. In 1997, he was awarded Distinguished Alumni Award from Northern American National Cheng Kung University Alumni Association. In March 2001, he has received a Partnering for Education award from The National Council of Negro Women, Northern California Sections. In December, 2001, Margaret and Hsing have received "Venture Culturists" award from DeAnza College. In 2002, he received "Asian American Hero 2002" award from County of Santa Clara. In April 2004, he received "Community Star Award" from Asian Americans for Community Involvement, and "Helen Tao Activist of Year" Award from Silicon Valley APA Democratic Club. He is also a Co-Founder and serves as Strategy Advisor at InnoLight.
Individual/Angel
Kodori
Switzerland
Founded in 2010, Kodori is an venture capital firm based in Zug, Switzerland. The firm prefers to invest in international companies based in Switzerland, Great Britain and other countries in the European Union.
Venture Capital
Koev Brothers
United States
Founded in 2019, Koev Brothers is a private equity firm and media group based in Washington, District of Columbia.
Growth Capital
Kohan Ventures
United States
Mr. Lavigne served as Board Member at Puppet and BMC Software. Mr. Lavigne serves as a Director at DocuSign. He is managing director of Lavrite, LLC and former Executive Vice President and Chief Financial Officer of Genentech Inc., leads DocuSign's Audit and Finance Committee. He brings decades of corporate finance, accounting, growth strategy and IT management experience to DocuSign's board. In his twenty-three years at Genentech, he led the company's financial, corporate relations and information technology groups as revenues grew from $40 million in 1983 to $300 million in 1988 when he became CFO to more than $6.5 billion in 2005 when he was named 'Best CFO in Biotech' by Institutional Investor. Mr. Lavigne is a Chairman and Member of the Board of Directors of Accuray, Inc. (Chairman of the Board & Compensation Committee), Allergan, Inc. (Member of the Audit and Finance & Science and Technology Committees), BMC Software (Chairman of the Audit Committee & Member of the M&A Committee), Depomed, Inc. (Audit Committee member), NovoCure (Audit Committee Chairman) and SafeNet, Inc. (Audit Committee Chairman). Previously, he was a Director and Chairman of the Audit Committee of several other public companies including Arena Pharmaceuticals, Equinix, Kyphon and Genova. Mr. Lavigne is also part of the Pacific SW Audit Committee Network of Audit Committee Chairs and Deloitte's Life Sciences Advisory Board. Mr. Lavigne is the managing member of Spring Development Group, LLC, a strategic investor in companies with unique growth opportunities. Mr. Lavigne is a board member and former Chairman of the UCSF Benioff Children's Hospitals. Mr. Lavigne is also a member of the West Coast Audit Committee Network and the faculty of the GLG Institute. He also served as Chairman of the Children's Hospital & Research Center Foundation. He serves as Board Member at Zynga.
Individual/Angel
Konstantin Stiskin
United States
Mr. Ari Buchler serves as Board Member at Simeio Solutions. He also serves as Corporate Director & Advisor at LinkSquares. He serves as Senior Advisor at Plum Acquisition I. He also serves as Limited Partner at Glilot Capital Partners. Furthermore, he also provides consulting and advisory services to companies in a number of industries. Previously, he served as Board Member at Midaxo and STI Technologies. He has over 20 years of global experience leading corporate development, legal, software OEM sales, and other corporate functions in both private and public companies. His M&A experience includes over 40 transactions around the globe and countless target sourcing and evaluations. He was a key member of the turn-around teams at Siris Capital-backed Intralinks (sold to SS&C) and Apax-backed Sophos (London IPO). He was also a senior executive at Rocket Software and Phase Forward. He helped scale Phase Forward from zero to over $220M in revenue, Nasdaq IPO, and subsequent sale to Oracle. Earlier in his career, he served as in-house counsel at Reed Business Information and as a corporate associate at the law firm of Skadden Arps. He has a law degree from Columbia University School of Law and a bachelor's degree in political science and a special honors curriculum from Hunter College of the City University of New York. He invests in early-stage startups as well as PE and venture funds.
Individual/Angel
KPS Capital
New York, New York, United States
KPS Capital focuses on constructive investing in turnarounds, restructurings, bankruptcies, employee buyouts, and other special situations.
Finance
Financial Services
Venture Capital
Private Equity Firm
Kraken
San Francisco, California, United States
Kraken is a cryptocurrency exchange that provides spot and futures trading between Bitcoin, Ethereum and 40+ other digital assets.
Asset Management
Blockchain
Cryptocurrency
Ethereum
Financial Exchanges
Financial Services
FinTech
Personal Finance
Stock Exchanges
Trading Platform
Corporate Venture Capital
KTECH Capital
Bellevue, Kentucky, United States
KTECH provides seed stage and other private equity funding to entrepreneurial businesses.
Private Equity Firm
Kuba Tymula
United States
Mr. Glen Sato served as a Partner at Cooley. He is also an Angel Investor. He is a partner in the Life Sciences and Public Securities practice groups and a member of Cooley Godward Kronish's Business department. He rejoined the Firm in 2006 and is resident in the Palo Alto office. Mr. Sato's practice focuses on corporate transactions, SEC reporting and compliance, disclosure issues, intellectual property licensing and licensing strategy, general corporate counseling, insider trading compliance and working with Boards of Directors and audit committees on various risk and accounting related matters. Together with strong finance capabilities, Sato also has substantial experience in corporate partnering, international and domestic M&A and other heavily negotiated transactions. He has worked closely with underwriters on public and private company acquisitions and led initial public, follow-on and secondary and convertible note offerings. He has also led or been significantly involved in corporate partnering and licensing transactions involving pharmaceutical and biotechnology companies such as Abbott, Bayer, Biogen Idec, Bristol-Myers Squibb, Exelixis, Eli Lilly, Genentech, GlaxoSmithKline, MedImmune, PDL BioPharma, Progenics, Roche, Sankyo and Tanox. Prior to joining the Firm, Mr. Sato served in diverse legal, financial, operational and strategic planning positions where his responsibilities included finance, business development, IS, HR and Facilities. He most recently served as Protein Design Labs' (PDL) Senior Vice President and Chief Financial Officer. He joined PDL from Exelixis, where he served as SVP, Chief Financial Officer and General Counsel for approximately three years. Prior to his time at Exelixis, he served in various legal and strategic planning positions at PDL, including Vice President, Legal and General Counsel. In addition, Mr. Sato worked at NeXT Computer as Associate General Counsel. He was an attorney in Cooley Godward Kronish's Business Department in Palo Alto for two years. Mr. Sato started his career at Jones, Day in Washington, DC. Mr. Sato received his JD and MBA from UCLA in 1987, where he was an Associate Editor of the Law Review. He received a Bachelor's degree in Economics and the College of Social Studies in 1981 from Wesleyan University. Mr. Sato is a member of the State Bar of California and an inactive member of the Washington, DC Bar Association.
Individual/Angel
L2 Capital Partners
Devon, Pennsylvania, United States
L2 Capital Partners provide a more flexible alternative to entrepreneurs and other business leaders seeking to grow their companies.
Asset Management
Venture Capital
Private Equity Firm
la Caixa
Barcelona, Catalonia, Spain
La Caixa is a Spanish private equity company focused on infrastructures, energy, and communications sectors, among others.
Investment Bank
Lake Street Capital
San Francisco, California, United States
Lake Street Capital is a leader in the secondary direct market. They are focused on acquiring venture capital, buyout and other private
Finance
Financial Services
Venture Capital
Venture Capital
Lalotte Ventures
United States
Crypto Dorm Fund is an investment firm. The firm seeks to develop and promote blockchain networks and technologies by providing investments and other supporting services.
Venture Capital
Lampe Capital Finance
Germany
Lampe Capital Finance, a part of the Bankhaus Lampe Group, is a mezzanine firm that specializes in private equity, management buy-outs, recapitalizations, restructuring and other situations. The firm is based in Dusseldorf, Germany and makes investments in medium-sized German firms.
Mezzanine Capital
Showing 721 to
740 of
1,258 results